Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Clinical trial NCT07356245 · RECRUITING

Trial details

NCT number: NCT07356245
Sponsor: Jonathan Brammer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

T-cell Lymphoma Graft Versus Host Disease Lymphoma, T-Cell Peripheral T Cell Lymphoma T-cell Prolymphocytic Leukemia Cutaneous T Cell Lymphoma Adult T-cell Leukemia/Lymphoma Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

Start date: 2026-02-12
Primary completion: 2026-12-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.